Overview
Updated 14 Jul 2026
Arshad M. Khanani, MD, is Managing Partner, Director of Clinical Research, and Director of Fellowship, Sierra Eye Associates. The public record shows 163 publications with 5,354 citations (h-index 34), centered on Retinal Diseases and Treatments, Ophthalmology and Visual Impairment Studies, Retinal Imaging and Analysis. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 43 companies.
- Most recent indexed publication: 2026 · Eye (London, England)
- Top research focus: Retinal Diseases and Treatments
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 43 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 83.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Sponsor: 4D Molecular Therapeutics
InvestigatorPhase 3RecruitingNCT07064759 - Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)
Sponsor: Sierra Eye Associates
InvestigatorPhase 2RecruitingNCT06942520 - A Study of EXG102-031 in Patients With wAMD (Everest)
Sponsor: Exegenesis Bio
InvestigatorPhase 1CompletedNCT05903794
Industry payments
Updated 14 Jul 2026
43 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Ocular Therapeutix, Inc.Program year202590 payments$115,232openpaymentsdata.cms.gov ↗
- Astellas Pharma US IncProgram year202536 payments$107,663openpaymentsdata.cms.gov ↗
- F. Hoffmann-La Roche AGProgram year202518 payments$51,025openpaymentsdata.cms.gov ↗
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Visual and Anatomic Outcomes of Faricimab in Naïve Neovascular Age-Related Macular Degeneration with Subretinal Hemorrhage: A Multi-Centre Retrospective Analysis.
Clinical ophthalmology (Auckland, N.Z.)
2026 - A novel modifier gene therapy to treat Stargardt disease: Phase 1 GARDian1 Trial Insights.
Eye (London, England)
2026
Most-cited worksby citation count (OpenAlex)
- 02
- 03
- 04TENAYA and LUCERNE188 citations2024
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
950 Ryland St, Reno, NV 89502
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD
Texas Tech University Health Sciences Center School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
- Ophthalmology residency
Texas Tech University Health Sciences Center (Chief Resident)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Vitreoretinal fellowship
UT Southwestern Medical Center, Dallas
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Board certified
American Board of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Editorial & leadership rolesjournal and society appointments
- Member
Macula Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗ - Member
Retina Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗ - Chair
Phase 3 GATHER2 Steering Committee (IZERVAY, geographic atrophy)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
Secondary affiliationsappointments beyond the home institution
- Clinical Professor
University of Nevada, Reno School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sierraeyeassociates.com ↗ - Scientific Advisory Board
Clearside Biomedical
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.clearsidebio.com ↗ - Team/Advisory role
4D Molecular Therapeutics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theophthalmologist.com ↗
- Host
"The Retina Radar with Dr. Arshad Khanani" video podcast series (Healio)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗ - Guest
"Retina Matters" video podcast (geographic atrophy OLE trial discussion)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/arshad-khanani-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/arshad-m-khanani-977596104
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
asrs.org/find-a-specialist/profile/8313/Arshad-M-Khanani
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - Other
healio.com/cme/mededtalks/ophthalmology/20241210/11-the-retina-radar-with-dr-arshad-khanani-emerging-therapeutics-in-late-stage-development/overview
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.